Sumitomo Dainippon Pharma Oncology

this page is no longer active or monitored. we are now sumitomo pharma america (smpa), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. see pinned post for our new page and follow us!⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ === sumitomo pharma oncology, inc. is a developer of novel cancer therapeutics based in the u.s. and a wholly owned subsidiary of sumitomo pharma co., ltd. this u.s. entity, together with the oncology research and development teams in japan, cancer research unit and oncology clinical development unit, will collectively be known as sumitomo pharma oncology or smp oncology. smp oncology is relentlessly committed to advancing purposeful science by transforming new discoveries into meaningful treatments for patients with cancer. our robust and diverse pipeline spans multiple areas, including oncogenic pathways, survival mechanisms and novel protein interactions,